Pharmacists in Edison, NJ Accepting Medicare

203 Pharmacists found. Showing 41 - 60

Mr. Richard G. Rumage Jr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 95 Newfield Ave Ste B, Edison, NJ 08837 Phone: 732-346-1333    Fax: 732-346-1999

Mrs. Elizabeth Bailey, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 120 Fieldcrest Ave, Edison, NJ 08837 Phone: 732-225-2635

Khushbu K Patel Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8 Eden Ave, Edison, NJ 08817 Phone: 732-248-7911

Krishna Jitu Patel, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 81 Glendale Ave, Edison, NJ 08817 Phone: 888-319-1818

Anita Cyriac Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1133 Inman Ave, Edison, NJ 08820 Phone: 908-753-0624

Anna Kravets, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 120 Fieldcrest Ave, Edison, NJ 08837 Phone: 800-444-5100    Fax: 800-838-4918

Dr. Hetal K Patel, PHARM-D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1197 Amboy Ave, Edison, NJ 08837 Phone: 732-549-3875    Fax: 732-549-3976

Sabitha Katpally Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 81 Plainfield Ave, Edison, NJ 08817 Phone: 732-985-2348

Sejal Patel Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1199 Amboy Ave, Edison, NJ 08837 Phone: 732-494-0677

Young Nam Ko, RPH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Parsonage Rd, Edison, NJ 08837 Phone: 732-744-0702    Fax: 732-744-0702

Josephine W Young, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 205 Vineyard Rd, Edison, NJ 08817 Phone: 732-491-2022

Mrs. Sejal D Patel, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 120 Fieldcrest Ave, Edison, NJ 08837 Phone: 732-346-2600

Mrs. Vandana H Patel Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 52 Lincoln Hwy, Edison, NJ 08820 Phone: 732-205-4900    Fax: 732-318-6635

Afua A Asante Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1199 Amboy Ave, Edison, NJ 08837 Phone: 732-494-0677

Shubhadeep Dutta, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 72 Idlewild Rd, Edison, NJ 08817 Phone: 848-229-1374

Aliena Dabhi Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 16 Dayton Dr Apt 91b, Edison, NJ 08820 Phone: 732-372-5994

Dr. Stephanie C Oguekwe, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 883 Us Highway 1, Edison, NJ 08817 Phone: 732-548-1901

Harpreet Pawar Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10 Lincoln Hwy, Edison, NJ 08820 Phone: 732-744-0705

Mr. Harendra J Bhatt, B.S R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30 Morning Glory Lane, Edison, NJ 08820 Phone: 908-251-5756

Gloria Lucila Dall'orso Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1199 Amboy Ave, Edison, NJ 08837 Phone: 732-494-0677

News Archive

Study shows how mutations in the BRCA1 gene lead to breast cancer

An international team of researchers led by Columbia University Medical Center's Herbert Irving Comprehensive Cancer Center and Sweden's Lund University has, for the first time, revealed how mutations in the BRCA1 gene lead to breast cancer.

Respiratory syncytial virus, the most common cause of pneumonia in children

RSV is a respiratory virus that infects the lungs and breathing passages. While most healthy people recover from RSV infection, it can be severe in infants. According to the United States Centers for Disease Control and Prevention (CDC), RSV is the most common cause of bronchiolitis (inflammation of the small airways in the lung) and pneumonia in children under 1 year of age in the nation.

Tolerx initiates confirmatory Phase 3 clinical trial to evaluate otelixizumab in new-onset type 1 diabetes

Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced the initiation of a confirmatory Phase 3 clinical trial to further evaluate otelixizumab in autoimmune new-onset type 1 diabetes. The confirmatory Phase 3 clinical trial is called DEFEND-2 (Durable-Response Therapy Evaluation For Early or New-Onset Type 1 Diabetes) and immediately follows successful completion of enrollment in the initial Phase 3 clinical trial, DEFEND-1, with results from DEFEND-1 expected in the first half of 2011.

Hospital-based quality improvement programs reduce early elective deliveries of babies

A study published today in Obstetrics & Gynecology shows that multistate, hospital-based quality improvement programs can be remarkably effective at reducing early elective deliveries of babies.

Direct radiolabeling of nanographene materials enhances bioimaging accuracy, reduces biases

Positron emission tomography plays a pivotal role for monitoring the distribution and accumulation of radiolabeled nanomaterials in living subjects. The radioactive metals are usually connected to the nanomaterial through an anchor, a so-called chelator, but this chemical binding can be omitted if nanographene is used, as American scientists report in the journal Angewandte Chemie

Read more Medical News

› Verified 1 days ago

• 1
• 2
• 3(current)
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11